The Jordan Food and Drug Administration: A culture of quality and continuous improvement

Authors

  • Hayel Mohammad Obeidat is Director General at the Jordan Food and Drug Administration
  • Lina al Kayyali Jordan Food and Drug Administration
  • Wesal al Haqaish Jordan Food and Drug Administration
  • Nidaa Bawaraesh Jordan Food and Drug Administration
  • Peter J. Pitts Center for Medicine in the Public Interest

DOI:

https://doi.org/10.5912/jcb671

Keywords:

regulation, pharmacovigilance, substandard pharmaceutical event, quality, safety, bioequivalance

Abstract

In November 2013, the Jordan Food and Drug Administration, in partnership with the Center for Medicine in the Public Interest, held a seminar entitled, “Advancing the Safe Use of Drugs: Enhancing Regulatory Quality Control.†Attendees included members of the JFDA leadership as well as representatives of Jordan’s healthcare community (hospitals, pharmacists, pharmaceutical manufacturers, academics). The seminar began a strategic thinking process aimed at enhancing a regulatory environment that values pharmaceutical manufacturing quality, the importance of stakeholder involvement, the urgent role of pharmacovigilance, and greater harmonization with advanced regulatory practices.  The goal was to develop realistic recommendations that can be implemented within existing authorities and resources; that serve the Jordanian public health; and enhance the stature and reputation of the JFDA as a regional reference and a global leader.

Author Biographies

Hayel Mohammad Obeidat, is Director General at the Jordan Food and Drug Administration

is Director General at the Jordan Food and Drug Administration

Lina al Kayyali, Jordan Food and Drug Administration

is Drug Director’s Assistant, Drug Directorate at the Jordan Food and Drug Administration

Wesal al Haqaish, Jordan Food and Drug Administration

is Head of Drugs Registration Department, Drug Directorate at the Jordan Food and Drug Administration

Nidaa Bawaraesh, Jordan Food and Drug Administration

is Head of Rational Drug Use, Drug Directorate at the Jordan Food and Drug Administration

Peter J. Pitts, Center for Medicine in the Public Interest

is President and co-founder of the Center for Medicine in the Public Interest

Downloads

Published

2014-09-27

Issue

Vol. 20 No. 4 (2014)

Section

Legal and Regulatory Updates